27
Aug
2024
FUJIAN COMHONY BIOTECHNOLOGY CO., LTD.
Exhibitor at CPHI Korea 2024 stand M32
About Us
Categories
-
CN
-
2018On CPHI since
-
4Certificates
-
250 - 499Employees
Company types
Primary activities
Event information
CPHI Korea 2024
-
27 - 29 August 2024
-
COEX, Seoul, Korea
-
Visit us at stand M32
Products Featured at CPHI Korea 2024
-
Product Amikacin Sulfate/ Sulphate
Support: DML, Written Confirmation, GMP Compliance, DMF. -
Product Mupirocin Calcium
Support: DML, Written Confirmation, GMP Compliance, CEP, DMF. -
Product Amikacin Sulfate
applicable to serious infections caused by sensitive gram-negative bacteria and staphylococcus (methicillin sensitive strains) such as bacteremia or septicemia, bacterial endocarditis, lower respiratory tract infection, bone and joint infection, biliary tract infection, abdominal infection, complex urinary... -
Product Daptomycin
Daptomycin is a cyclic lipopeptide antibiotic derived from the organism Streptomyces roseosporus. Daptomycin is used to treat various bacterial infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE).
... -
Product Fusidic Acid, Sodium Fusidate
Fusidic acid is highly sensitive to various gram-positive coccus related to skin infections, especially aureus. Also effective to resistant staphylococcus aureus
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance